Menu
GWAS Study

The 2018 Otto Aufranc Award: How Does Genome-wide Variation Affect Osteolysis Risk After THA?

MacInnes SJ, Hatzikotoulas K, Fenstad AM et al.

30794219 PubMed ID
GWAS Study Type
3514 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MS
MacInnes SJ
HK
Hatzikotoulas K
FA
Fenstad AM
SK
Shah K
SL
Southam L
TI
Tachmazidou I
HG
Hallan G
DH
Dale H
PK
Panoutsopoulou K
FO
Furnes O
ZE
Zeggini E
WJ
Wilkinson JM
Chapter II

Abstract

Summary of the research findings

Periprosthetic osteolysis resulting in aseptic loosening is a leading cause of THA revision. Individuals vary in their susceptibility to osteolysis and heritable factors may contribute to this variation. However, the overall contribution that such variation makes to osteolysis risk is unknown.

1,096 European ancestry cases, 2,418 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

3514
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Norway, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.